# A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers

> **NCT00938275** · PHASE1 · COMPLETED · sponsor: **Sirtris, a GSK Company** · enrollment: 20 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** 0.5g SRT2104

## Key facts

- **NCT ID:** NCT00938275
- **Lead sponsor:** Sirtris, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-20
- **Primary completion:** 2009-03-27
- **Final completion:** 2009-03-27
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938275, "A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00938275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*